Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Novocure revenue
Novocure's revenue is $535.0 million.
What is Novocure's revenue?
- Novocure's revenue growth from 2014 to 2021 is 3,354.04%.
- Novocure has 1,167 employees, and the revenue per employee ratio is $458,467.
- Novocure's peak quarterly revenue was $155.1M in 2024(q3).
- Novocure peak revenue was $535.0M in 2021.
- Novocure annual revenue for 2020 was 494.4M, 40.72% growth from 2019.
- Novocure annual revenue for 2021 was 535.0M, 8.23% growth from 2020.
On this page
Zippia finds jobs where you're a top candidate and applies on your behalf.
Novocure historical revenue
Novocure's peak revenue was $535.0M in 2021. The peak quarterly revenue was $155.1M in 2024(q3).
Novocure's revenue increased from $15.5m in 2014 to $535.0M currently. That's a 3,354.04% change in annual revenue.
Novocure annual revenue
Novocure annual revenue over time
| Fiscal year / year | Novocure revenue |
|---|---|
| 2014 | $15.5M |
| 2015 | $33.1M |
| 2016 | $82.9M |
| 2017 | $177.0M |
| 2018 | $248.1M |
| 2019 | $351.3M |
| 2020 | $494.4M |
| 2021 | $535.0M |
How accurately did Novocure's revenue projections match actual performance?
Novocure annual growth
Novocure saw the greatest revenue growth in 2016, when revenue increased by 150.52%.
Novocure had the lowest revenue growth in 2022, when revenue changed by 0.53%.
Novocure annual growth rate over time
| Year | Novocure growth |
|---|---|
| 2015 | 114%↑ |
| 2016 | 151%↑ |
| 2017 | 114%↑ |
| 2018 | 40%↑ |
| 2019 | 42%↑ |
| 2020 | 41%↑ |
| 2021 | 8%↑ |
Novocure jobs nearby
Do you work at Novocure?
Did Novocure meet its revenue projections?
Novocure financial information
| CEO | Asaf Danziger |
| Industry | Pharmaceuticals, Biotechnology & Life Sciences |
| Company Type | Public |
| Employees Number | 1,167 |
| Date Founded | 2000 |
| Headquarters | Portsmouth, New Hampshire |
| Number of Locations | 3 |
| Revenue | $535.0M |
| Net Income | -$92,534,000 |
| Gross Proft | $420.2M (2021) |
| Tax Rate | -0.1% |
| Total Assets | $1,191,648,000 |
| Ticker | NVCR |
Novocure jobs you might like
Novocure financing
Novocure received early financing of $150.0M on 2018-02-07.
| Series | Round size | Date |
|---|---|---|
| Post Ipo Debt | $150M | 02/2018 |
| Post Ipo Debt | $575M | 11/2020 |
| Post Ipo Debt | $150M | 11/2020 |
Novocure investors
| Investors | Security type |
|---|---|
| BioPharma Credit | Post Ipo Debt |
| JPMorgan Chase & Co. | Post Ipo Debt |
Novocure competitors
Novocure's top competitor, Kaiser Permanente, earned an annual revenue of $88.7B.
Novocure's smallest competitor is Employers Health with revenue of $2.4M last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Salient Surgical Technologies | $46,285 | $1.6M | 18 | - |
| Partners Health Management | $46,270 | $33.5M | 200 | 45 |
| UBC | $49,910 | $105.3M | 1,001 | 4 |
| ValueOptions | $47,667 | $5.5M | 70 | - |
| Kaiser Permanente | $47,863 | $88.7B | 304,220 | 4,085 |
| National Healthcare Resources, Inc. | $42,833 | $1.4M | 30 | 11 |
| BJC HealthCare | $38,814 | $4.0B | 27,191 | 1,488 |
| Foundations Recovery Network | $48,689 | $260.0M | 3,000 | 1 |
| Bay-arenac Behavioral Health | $38,959 | $30.0M | 350 | - |
| Oak Street Health | $36,397 | $2.2B | 2,300 | 8 |
Search for jobs
Related company revenues
Working at related companies
Related company jobs
Novocure highest paying jobs
Zippia gives an in-depth look into the details of Novocure, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Novocure. The employee data is based on information from people who have self-reported their past or current employments at Novocure. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Novocure. The data presented on this page does not represent the view of Novocure and its employees or that of Zippia.
Novocure may also be known as or be related to NovoCure, Novocure, Novocure Inc and Novocure Inc.